Advertisement

The Scientist

» drug development and immunology

Most Recent

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

image: Loss of Microtubule Regulator Blocks Sperm Maturation

Loss of Microtubule Regulator Blocks Sperm Maturation

By | May 24, 2012

New research suggests that controlling cytoskeletal dynamics in sperm accessory cells may help regulate male fertility.

0 Comments

image: US Drug Approvals Top Canada, Europe

US Drug Approvals Top Canada, Europe

By | May 18, 2012

The FDA approves drugs faster and earlier than regulatory agencies in other countries.

3 Comments

image: FDA Eases Sterility Requirements

FDA Eases Sterility Requirements

By | May 16, 2012

The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.

1 Comment

image: Approving

Approving

By | May 14, 2012

The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.

0 Comments

image: Rural Teens Have Fewer Allergies

Rural Teens Have Fewer Allergies

By | May 8, 2012

The diversity of microbes in the great outdoors may protect against inflammatory disorders.

2 Comments

image: Pure Pursuits

Pure Pursuits

By | May 1, 2012

Techniques for simpler, cheaper, and better antibody purification

0 Comments

image: Tumor Turnabout

Tumor Turnabout

By | May 1, 2012

A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.

4 Comments

image: Freezing Time

Freezing Time

By | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

Advertisement

Popular Now

  1. Antibiotics and the Gut Microbiome
  2. Sex Differences in Pain Pathway
  3. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  4. Anti-Vax Doctor Found Dead
    The Nutshell Anti-Vax Doctor Found Dead

    Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.

Advertisement
Advertisement
The Scientist